Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug

Ophthalmic Research

Volumn 40, Issue 6, 2008, Pages 298-308

  Denoyer, Alexandre ^a,b   Ossant, Frederic ^b   Arbeille, Brigitte ^a   Fetissof, Franck ^a   Patat, Frederic ^b   Pourcelot, Léandre ^b   Pisella, Pierre Jean ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Benzalkonium chloride; Corneal epithelium; Glaucoma medication; Ocular toxicity; Preservative; Timolol; Very high frequency ultrasound

Indexed keywords

ANTIGLAUCOMA AGENT; BENZALKONIUM CHLORIDE; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORNEA EDEMA; CORNEA EPITHELIUM; CORNEA INJURY; EARLY DIAGNOSIS; ECHOOCULOGRAPHY; EYE TOXICITY; HISTOLOGY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAINING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZALKONIUM COMPOUNDS; CONJUNCTIVAL DISEASES; CORNEA; EPITHELIUM, CORNEAL; KERATITIS; MALE; MICROSCOPY, ELECTRON, SCANNING; PRESERVATIVES, PHARMACEUTICAL; PROSPECTIVE STUDIES; RABBITS; RADIO WAVES; TIMOLOL; ULCER;

EID: 54549120427     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134928     Document Type: Article

References (60)

1. Sherar MD, Starkoski BG, Foster FS: A 100-MHz B-scan ultrasound backscatter microscope. Ultrason Imaging 1989;11:95-105.
2. Pavlin CJ, Sherar MD, Foster FS: Subsurfacing imaging of the eye by ultrasound biomicroscopy. Ophthalmology 1990;97:244-250.
3. Pavlin CJ, McWhae J, Foster FS: Ultrasound biomicroscopy of anterior segment tumours. Ophthalmology 1992;99:1220-1228.
4. Pavlin CJ, Ritch R, Foster FS: Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol 1992;113:390-395.
5. Heilighenhaus A, Schilling M, Lung E, Steuhl K: Ultrasound biomicroscopy in scleritis. Ophthalmology 1998;105:527-534.
6. Maberly D, Pavlin CJ, McGowan H, Foster FS, Simpson E: Ultrasound biomicroscopy imaging of the anterior aspect of peripheral choroidal melanomas. Am J Ophthalmol 1997;123:506-514.
7. Pavlin CJ, Christopher DA, Burns PN, Foster FS: High frequency Doppler examination of the anterior segment of the eye. Am J Ophthalmol 1998;126:597-600.
8. Foster FS, Pavlin CJ, Harasiewicz KA, Christopher DA, Turnbull DH: Advances in ultrasound biomicroscopy. Ultrasound Med Biol 2000;26:1-27.
9. Silvermann RH, Rondeau MJ, Lizzi FL, Coleman DJ: Three-dimensional high-frequency ultrasonic parameter imaging of anterior segment pathology. Ophthalmology 1995;102:837-843.
10. Reinstein DZ, Silvermann RH, Raevsky T, et al: Arc-scanning very high-frequency digital ultrasound for 3D pachymetric mapping of the corneal epithelium and stroma in laser in situ keratomileusis. J Refract Surg 2000;16:414-430.
11. Reinstein DZ, Silverman RH, Trokel SL, Coleman DJ: Corneal pachymetric topography. Ophthalmology 1994;101:432-438.
12. Tam ES, Rootman DS: Comparison of central corneal thickness measurements by specular microscopy, ultrasound pachymetry and ultrasound biomicroscopy. J Refract Surg 2003;29:1179-1184.
13. Reinstein DZ, Aslanides IM, Silverman RH, Asbell PA, Coleman DJ: High-frequency ultrasound corneal pachymetry in the assessment of corneal scars for therapeutic planning. CLAO J 1994;20:198-203.
14. Silverman RH, Reinstein DZ, Raevsky T, Coleman DJ: Improved system for sonographic imaging and biometry of the cornea. J Ultrasound Med 1997;16:117-124.
15. Burnstein NL: Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980;25:15-30.
16. Burnstein NL: Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci 1980;19:308-313.
17. Gasset AR: Benzalkonium chloride toxicity on the human cornea. Am J Ophthalmol 1977;84:169-171.
18. De Saint-Jean M, Brignole F, Bringuier AF, et al: Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999;40:619-630.
19. Grant RL, Acosta D: Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in primary culture system of rabbit corneal epithelial cells. Fundam Appl Toxicol 1996;33:71-82.
20. Cha SH, Lee JS, Oum BS, Kim SC: Corneal epithelial cellular dysfunction from benzalkonium chloride in vitro. Clin Experiment Ophtalmol 2004;32:180-184.
21. Green K, Johnson RE, Chapman JM, Nelson E, Cheeks L: Preservative effects on the healing rate of rabbit corneal epithelium. Lens Eye Toxic Res 1989;6:37-41.
22. Paugh JR, Sasai A, Joshi A: Preservative effect on epithelial barrier function measured with novel technique. Adv Exp Med Biol 1998;438:731-735.
23. Draize JH, Woodard G, Calvery HO: Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944;82:377-390.
24. Adriaens E, Dierckens K, Bauters TG, et al: The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs. Pharm Res 2001;18:937-942.
25. Martins T, Pauluhn J, Machemer L: Analysis of alternative methods for determining ocular irritation. Food Chem Toxicol 1992;30:1061-1067.
26. Kennah HE, Hignet S, Laux PE, Dorko JD, Barrow CS: An objective procedure for quantitating eye irritation based upon changes of corneal thickness. Fundam Appl Toxicol 1989;12:258-268.
27. Maurer JK, Li HF, Petrol WM, et al: Confocal microscopic characterization of initial corneal changes of surfactant-induced eye irritation in the rabbit. Toxicol Appl Pharmacol 1997;143:291-300.
28. Baudouin C, Pisella PJ, Fillacier K, et al: Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106:556-563.
29. Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C: Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res 2000;32:3-8.
30. Pisella PJ, Debbasch C, Hamard P, et al: Conjunctival proinflammatory and proapoptotic of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 2004;45:1360-1368.
31. Hitchings RA, Grierson I: Clinico-pathological correlation in eyes with failed fistulizing surgery. Eye 1983;103:84-86.
32. Agarwal HC, Sharma TK, Sihota R, Gulati V: Cumulative effects on risk factors on short-term surgical success of mitomycin augmented trabeculectomy. J Postgrad Med 2002;48:92-96.
33. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA: The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 1990;108:1543-1550.
34. Broadway DC, Grierson I, O'Brien C, Hitchings RA: Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112:1446-1454.
35. Mac Dowell EM, Trump BJ: Histological fixative suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 1976;100:405-414.
36. Berdy GJ, Abelson MB, Smith LM, et al: Preservative-free artificial tear preparations: assessment of corneal epithelial toxic effects. Arch Ophthalmol 1992;110:528-532.
37. Noecker RJ, Herrygers LA, Anwaruddin R: Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 2004;23:490-496.
38. Pisella PJ, Pouliquen P, Baudouin C: Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002;86:418-423.
39. Barabino S, Dana MR: Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci 2004;45:1641-1646.
40. Nakamura S, Okada S, Umeda Y, Saito F: Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations. Cornea 2004;23:390-397.
41. Wilson WS, Duncan AJ, Jay JL: Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol 1975;59:667-669.
42. Nagelhout TJ, Gamache DA, Roberts L, et al: Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in rabbit model of lacrimal gland inflammation-induced dry eye. J Ocul Pharmacol Ther 2005;21:139-148.
43. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A: Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci 1997;16:475-481.
44. Martinez AJ, Mills MB, Jaceldo KB, et al: Standardisation of conjunctival impression cytology. Cornea 1995;14:515-522.
45. Ichijima H, Petroll WM, Jester JV, Cavanagh HD: Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 1992;11:221-225.
46. Jester JV, Maurer JK, Petroll WM, et al: Application of in vivo confocal microscopy to the understanding of surfactant-induced ocular irritation. Toxicol Pathol 1996;24:412-428.
47. Furrer P, Plazonnet B, Mayer JM, Gurny R: Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm 2000;207:89-98.
48. Haruta Y, Ohashi Y, Matsuda S: Corneal epithelial deficiency induced by the use of betablocker eye drops. Eur J Ophthalmol 1997;7:334-339.
49. Tripathi BJ, Tripathi RC, Kolli SP: Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Toxic Res 1992;9:361-375.
50. Wang YD, Kashiwagi K, Chen HB, et al: Effects of isopropyl unoprostone ophthalmic solution on cultured rabbit corneal epithelial cells. Ophthalmologica 2001;215:229-234.
51. De Jong C, Stolwijk T, Kuppens E, et al: Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol 1994;232:221-224.
52. Collin HB: Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives. Acta Ophthalmol (Copenh) 1986;64:72-78.
53. Collin HB, Carroll N: Ultrastructural changes to the corneal endothelium due to benzalkonium chloride. Acta Ophthalmol (Copenh) 1986;64:226-231.
54. Chodosh J, Dix RD, Clark Howell R, Stroop WG, Tseng SC: Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B . Invest Ophthalmol Vis Sci 1994;35:1046-1058.
55. Jester JV, Li HF, Petroll WM, et al: Area and depth of surfactant-induced corneal injury correlates with cell death. Invest Ophthalmol Vis Sci 1998; 39: 922-936.
56. Jester JV, Petroll WM, Bean J, et al: Area and depth of surfactant-induced corneal injury predicts extent of subsequent ocular responses. Invest Ophthalmol Vis Sci 1998;39:2610-2625.
57. Ye SG, Harasiewicz KA, Pavlin CJ, Foster FS: Ultrasound characterisation of normal ocular tissue in the frequency range from 50 MHz to 100 MHz. IEEE Trans Ultrason Ferroelectr Freq Control 1995; 42: 8-14.
58. Mietz H, Niesen U, Krieglstein GK: The effect of preservatives and antiglaucomatous medication on histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 1994; 232: 561-565.
59. Broadway DC, Grierson I, O'Brien C, Hitchings RA: Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 1994;112:1437-1445.
60. Ihan A, Cvenkel B: Conjunctival epithelium expression of HLA-DR in glaucoma patients and its influence on the outcome of filtration surgery. Br J Ophthalmol 2000;84:648-650.